Human Gm, Km, and Am Allotypes: WHO/IMGT Nomenclature and IMGT Unique Numbering for Immunoinformatics and Therapeutical Antibodies
Abstract
:1. Introduction
2. Allotype and Isoallotype
2.1. Human IG Allotype Discovery
2.2. Gm, Am, and Km Allotype Definition
2.3. Allotype Nomenclature
2.4. Allotype Determination
2.4.1. Hemagglutination Inhibition Methodology
2.4.2. Other Methodologies
2.5. Gm (or Gm–Am) Phenotype and Genotype Deduction
2.6. Allotype Localization on Domains and Correlation with Amino Acid Changes
2.7. Isoallotypes
2.8. Protein Displays and IMGT Colliers de Perles
2.9. IMGT Correspondence between “Gm, Am, or Km Allele” and “Gene Allele”
3. G1m Allotypes and nG1m Isoallotypes
3.1. G1m1 Allotype and nG1m1 Isoallotype
3.2. G1m2 Allotype
3.3. G1m3 and G1m17 Allotypes and nG1m17 Isoallotype
3.4. G1m27 and G1m28 Allotypes
3.5. IMGT Correspondence between G1m Alleles and IGHG1 Alleles
4. G2m Allotype
4.1. G2m23 Allotype
4.2. IMGT Correspondence between the G2m Alleles and IGHG2 Alleles
5. G3m Allotypes and nG3m
5.1. G3m Allotypes and IGHG3 Sequences
5.2. First Mosaic: G3m6, G3m10, G3m11, G3m13, G3m24, G3m27, and Antithetical Isoallotype nG3m11
- -
- G3m10 corresponds to the simultaneous expression of S44 (G3m11) with an isoleucine at position 101 (IGHG3 CH3 Ile I101) [2];
- -
- G3m24 corresponds to the simultaneous expression of S44 (G3m11) with a valine at position 101 (IGHG3 CH3 Val V101) [2];
- -
- G3m6 corresponds to the simultaneous expression of S44 (G3m11) with a glutamate at position 98 (IGHG3 CH3 Glu E98) [2].;
- -
- G3m13 corresponds to the simultaneous expression of S44 (G3m11) with a glutamine at position 98 (IGHG3 CH3 Gln Q98) [2].
5.3. Second Mosaic: G3m5, G3m28, G3m26, and Antithetical Isoallotype nG3m5
- -
- G3m28 corresponds to the simultaneous expression of arginine at position 115 (IGHG3 CH3 Arg R115) and tyrosine at position 116 (IGHG3 CH3 Tyr Y116). This observation is in agreement with the genetic data that show that G3m5 and G3m28 are antithetical and mutually exclusive on the gamma3 chains [2].
5.4. G3m14 and G3m15
5.5. G3m16 and G3m21 Allotypes
5.6. “Silent” G3m Allotypes
5.7. “Surnumerary” Gm27 and Gm28 Allotypes
5.8. Correlation between G3m Allotypes and Isoallotypes and Amino Acids
5.9. IGHG3 Hinge CNV Exon Polymorphism
5.10. G3m Alleles and the “IMGT G3m Allele Butterfly” Representation
5.11. Correspondence between the G3m Alleles and IGHG3 Alleles
6. nG4m Isoallotypes
6.1. nG4m(a) and nG4m(b) Isoallotypes
6.2. IMGT Correspondence between G4m Alleles and IGHG4 Alleles
7. A2m Allotypes and nA2m Isoallotype
7.1. A2m1 and A2m2 Allotypes
7.2. A2m1 and A2m2 Allotype Frequency
7.3. A2m1 and A2m2 Allotype Determination by RFLP
7.4. Sequence Identity and Conformational Difference for A2m1 and the alpha1 Isotypic Epitope
7.5. A2m3 Allotype Antithetical to nA2m3
7.6. IMGT Correspondence between A2m Alleles and IGHA2 Alleles
8. Gm Haplotypes
8.1. Gm (or Gm–Am) Haplotype Definition
8.2. Description of the Main Gm Haplotypes
8.3. Prevalent Gm Haplotypes in Different Populations
8.4. From Gm Phenotypes to Gm Genotypes and Haplotypes
8.5. Gm Haplotype Frequency in Different Populations
9. Km Allotypes
9.1. Definition
9.2. Km Allotype Determination, Km Phenotypes, and Km Genotypes
- -
- The six Km genotypes defined by their Km alleles;
- -
- The five Km phenotypes observed when sera are tested for the three allotypes Km1, Km2, and Km3;
- -
- The three Km phenotypes observed when sera are only tested for allotypes Km1 and Km2;
- -
- The two Km phenotypes observed when sera are only tested for allotype Km1.
Km Genotypes | Km Phenotypes | ||
---|---|---|---|
Sera Tested for Allotypes Km1, Km2, and Km3 | Sera Only Tested for Allotypes Km1 and Km2 | Sera Only Tested for Allotype Km1 | |
Km1/Km1 | Km1 | Km1,-2 | Km1 |
Km1/Km3 | Km1,3 | ||
Km1/Km1,2 or Km1,2/Km1,2 | Km1,2 | Km1,2 | |
Km1,2/Km3 | Km1,2,3 | ||
Km3/Km3 | Km3 | Km-1,-2 | Km-1 |
9.3. Km Phenotypes and Km Allele Frequencies in Different Populations
9.4. IMGT Correspondence between Km Alleles and IGKC Allele Names
10. Discussion
Supplementary Materials
Author Contributions
Funding
Data Availability Statement
Acknowledgments
Conflicts of Interest
Appendix A
Gm Haplotypes | Gm Haplotypes a (WHO/IMGT Nomenclature) | Previous Designation b |
---|---|---|
A | Gm5*;3;23 | Gmb*;f;n |
B | Gm5*;3;.. | Gmb*;f;.. |
C | Gm21*;17,1;.. | Gmg*;z,a;.. |
D | Gm21*;17,1,2;.. | Gmg*;z,a,x;.. |
E | Gm5*;17,1;.. | Gmb*;z,a;.. |
F | Gm6*;17,1;.. | Gmc3*;z,a;.. |
G | Gm24*;17,1;.. | Gmc5*;z,a;.. |
H | Gm15*;17,1;.. | Gms*;z,a;.. |
I | Gm16*;17,1;.. | Gmt*;z,a;.. |
J | Gm5*;3,1;23 | Gmb*;f,a;n |
K | Gm5*;3,1;.. | Gmb*;f,a;.. |
L | Gm5*;17,1,2;.. | Gmb*;z,a,x;.. |
M | Gm21*;17,1;23 | Gmg*;z,a;n |
Appendix B
IGHG1 Alleles | G1m Alleles a | IMGT Amino Acid Positions b | Populations [2] and This Paper | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Allotypes | Isoallotype c | CH1 | CH3 | ||||||||
103 | 120 | 12 | 14 | 101 | 110 | 115 | 116 | ||||
G1m17/nG1m17 | G1m1/ nG1m1 | /G1m27 | /G1m2 | /G1m28 - | |||||||
G1m3 d | |||||||||||
IGHG1*01, IGHG1*02, IGHG1*05, IGHG1*09 | G1m17,1 | I | K | D | L | V | A | H | Y | Caucasoid Negroid Mongoloid | |
IGHG1*03, IGHG1*06 | G1m3 | nG1m1, nG1m17 | I | R | E | M | V | A | H | Y | Caucasoid |
IGHG1*04 | G1m17,1,27 | I | K | D | L | I | A | H | Y | Negroid | |
IGHG1*07 | G1m17,1,2 | I | K | D | L | V | G | H | Y | Caucasoid Mongoloid | |
IGHG1*08 | G1m3,1 | nG1m17 | I | R | D | L | V | A | H | Y | Mongoloid |
IGHG1*05p e | G1m17,1,28 | I | K | D | L | V | A | R | Y | Negroid | |
IGHG1*06p e | G1m17,1,27,28 | I | K | D | L | I | A | R | Y | Negroid | |
IGHG1*09p e | G1m17 | nG1m1 | I | K | E | M | V | A | H | Y | Caucasoid |
IGHG1*01v | G1m3,1 | nG1m17 | I | R | D | L | V | A | H | Y | engineered |
IGHG1*03v | G1m17 | nG1m1 | I | K | E | M | V | A | H | Y | engineered |
Appendix C. IMGT Repertoire (IG and TR): Allotypes Gm, Km and Am and Isotypes IGLC
References
- Lefranc, M.-P.; Lefranc, G. Molecular genetics of immunoglobulin allotype expression. In The Human IgG Subclasses: Molecular Analysis of Structure, Function and Regulation; Shakib, F., Ed.; Pergamon: Oxford, UK, 1990; Chapter 4; pp. 43–78. [Google Scholar]
- Lefranc, M.-P.; Lefranc, G. Human Gm, Km and Am allotypes and their molecular characterization: A remarkable demonstration of polymorphism. In Immunogenetics; Christiansen, F., Tait, B., Eds.; Humana Press: New York, NY, USA, 2012; Volume 882, Chapter 34; pp. 635–680. [Google Scholar]
- Grubb, R. Agglutination of erythrocytes coated with “incomplete” anti-Rh by certain rheumatoid arthritic sera and some other sera. The existence of human serum groups. Acta Pathol. Microbiol. Scand. 1956, 39, 195–197. [Google Scholar] [CrossRef] [PubMed]
- Grubb, R.; Laurell, A.B. Hereditary serological human serum groups. Acta Pathol. Microbiol. Scand. 1956, 39, 390–398. [Google Scholar] [CrossRef] [PubMed]
- Harboe, M.; Lundevall, J. A new type in the Gm system. Acta Pathol. Microbiol. Scand. 1959, 45, 357–370. [Google Scholar] [CrossRef] [PubMed]
- Steinberg, A.G.; Wilson, J.A. Studies on hereditary gamma globulin factors: Evidence that Gm(b) in Whites and Negroes is not the same and that Gm-like is determined by an allele at the Gm locus. Am. J. Hum. Genet. 1963, 15, 96–105. [Google Scholar] [PubMed]
- Gold, E.R.; Ropartz, C.; Rivat, L.; Rousseau, P.Y. Gm(f)- a determinant of human gamma-globulin. Vox Sang. 1965, 10, 299–302. [Google Scholar]
- Gold, E.R.; Mandy, W.J.; Fudenberg, H.H. Relation between Gm(f) and the structure of the gamma-globulin molecule. Nature 1965, 207, 1099–1101. [Google Scholar] [CrossRef]
- Litwin, S.D.; Kunkel, H.G. A gamma-globulin genetic factor related to Gm(a) but localized to a different portion of the same heavy chains. Nature 1966, 21, 866. [Google Scholar] [CrossRef]
- Kunkel, H.G.; Yount, W.J.; Litwin, S.D. Genetically determined antigen of the Ne subgroup of gamma-globulin: Detection by precipitin analysis. Science 1966, 154, 1041–1043. [Google Scholar] [CrossRef]
- Harboe, M. A new hemagglutinating substance in the Gm system, anti-Gmb. Acta Pathol. Microbiol. Scand. 1959, 47, 191–198. [Google Scholar] [CrossRef]
- Steinberg, A.G.; Giles, B.D.; Stauffer, R. A Gm-like factor present in Negroes and rare or absent in whites: Its relation to Gma and Gmx. Am. J. Hum. Genet. 1960, 12, 44–51. [Google Scholar]
- Ropartz, C.; Rivat, L.; Rousseau, P.Y. Le Gm(b) et ses problèmes. Vox Sang. 1963, 8, 717–723. [Google Scholar] [CrossRef]
- Steinberg, A.G.; Goldblum, R. A genetic study of the antigens associated with the Gm(b) factor of human γ-globulin. Am. J. Hum. Genet. 1965, 17, 133–147. [Google Scholar]
- Martensson, L.; van Loghem, E.; Matsumoto, H.; Nielsen, J. Gm(s) and Gm(t): Genetic determinants of human gamma-globulin. Vox Sang. 1966, 11, 393–418. [Google Scholar] [CrossRef]
- Natvig, J.B. Gm(g)—A “new” gamma-globulin factor. Nature 1966, 211, 318–319. [Google Scholar] [CrossRef]
- Van Loghem, E.; Martensson, L. Genetic (Gm) determinants of the γ2c (Vi) subclass of human IgG immunoglobulins: A study with special reference to Gm(c3) and Gm(c5), and their relationship with the Gm(b) determinants. Vox Sang. 1967, 13, 369–392. [Google Scholar] [CrossRef]
- Van Loghem, E.; Grobbelaar, B.G. A new genetic marker of human IgG3 immunoglobulin. Evolutionary dissociation of Gm allotypes. Vox Sang. 1971, 21, 405. [Google Scholar] [CrossRef]
- Schanfield, M.S.; Fudenberg, H.H. Gm (Ray), a new allotypic marker on human IgG3. Vox Sang. 1974, 26, 133–140. [Google Scholar] [CrossRef]
- Blanc, M.; Dugoujon, J.M.; Ruffié, J. [A new genetic marker for human IgG3 usually associated with Gm (21) factor found in the caucasian and mongolian populations]. Un nouveau marqueur génétique des IgG3 humaines habituellement associé au facteur Gm(21) dans les populations caucasoides et mongoloides. C. R. Acad. Sci. Paris 1976, 283, 1461–1463. (In French) [Google Scholar]
- Van Loghem, E.; Blanc, M.; de Lange, G. Human IgG3 allotypes, with special reference to a new allotype related to G3m(g) (G3m(21)). J. Immunogenet. 1977, 4, 371–383. [Google Scholar] [CrossRef]
- Vyas, G.N.; Fudenberg, H.H. Am(1), the first genetic marker of human immunoglobulin A. Proc. Natl. Acad. Sci. USA 1969, 64, 1211–1216. [Google Scholar] [CrossRef]
- Kunkel, H.G.; Smith, W.K.; Joslin, F.G.; Natvig, J.B.; Litwin, S.D. Genetic marker of the gamma-A2 subgroup of γA immunoglobulins. Nature 1969, 223, 1247–1248. [Google Scholar] [CrossRef] [PubMed]
- Van Loghem, E.; Wang, A.; Shuster, J. A new genetic marker of human immunoglobulins determined by an allele at the α2 locus. Vox Sang. 1973, 24, 481–488. [Google Scholar] [CrossRef] [PubMed]
- Ropartz, C.; Lenoir, J.; Rivat, L. A new inheritable property of human sera: The Inv factor. Nature 1961, 189, 586–587. [Google Scholar] [CrossRef]
- Ropartz, C.; Rivat, L.; Rousseau, P.Y. Deux Nouveaux Facteurs dans les Systèmes Héréditaires de Gammaglobuline: Le Gm(e) et l’Inv(l). In Proceedings of the 9th Society of Blood Transfusion, Mexico City, Mexico, 5–12 September 1962; Karger: Basel, Switzerland, 1962; p. 455. [Google Scholar]
- Steinberg, A.G.; Wilson, J.A.; Lanset, S. A new human gamma globulin factor determined by an allele at the Inv locus. Vox Sang. 1962, 7, 151–156. [Google Scholar] [CrossRef] [PubMed]
- WHO. Review of the notation for the allotypic and related markers of human immunoglobulins—WHO meeting on human immunoglobulin allotypic markers. J. Immunogenet. 1976, 3, 357–362. [Google Scholar] [CrossRef]
- WHO. Review of the notation for the allotypic and related markers of human immunoglobulins—WHO meeting on human immunoglobulin allotypic markers held in Rouen, France, 16–19 July 1974. Eur. J. Immunol. 1976, 6, 599. [Google Scholar]
- Lefranc, G.; Loiselet, J.; Rivat, L.; Ropartz, C. Gm, Km and ISf allotypes in the Lebanese population. Acta Anthropog. 1976, 1, 34–45. [Google Scholar]
- Lefranc, G.; Rivat, L.; Rivat, C.; Loiselet, J.; Ropartz, C. Evidence for “deleted” or “silent” genes homozygous at the locus coding for the constant region of the γ3 chain. Am. J. Hum. Genet. 1976, 28, 51–61. [Google Scholar]
- Lefranc, G.; Rivat, L.; Salier, J.P.; van Loghem, E.; Aydenian, H.; Zalzal, P.; Chakhachiro, L.; Loiselet, J.; Ropartz, C. Recombination, mutation, or constitutive expression at a Gm locus and familial hypergammaglobulinemia. Am. J. Hum. Genet. 1977, 29, 523–536. [Google Scholar]
- Lefranc, G. Allotypes et Haplotypes des Immunoglobulines dans les Communautés Libanaises: Intérêt Exceptionnel en Immunogénétique et Séro-Anthropologie. Ph.D. Thesis, Université de Rouen, Rouen, France, 1978. (In French). [Google Scholar]
- Lefranc, G. Immunoglobulin Allotypes and Haplotypes in the Lebanese Communities: Discussion of Unusual Genetic Events and Population Structure. Ph.D. Thesis, Université de Rouen, Rouen, France, 1978; pp. 1–137. [Google Scholar]
- Lefranc, G.; Rivat, L.; Serre, J.L.; Lalouel, J.M.; Pison, G.; Loiselet, J.; Ropartz, C.; de Lange, G.; van Loghem, E. Common and uncommon immunoglobulin haplotypes among Lebanese communities. Hum. Genet. 1978, 41, 197–209. [Google Scholar] [CrossRef]
- Lefranc, G.; de Lange, G.; Rivat, L.; Langaney, A.; Lefranc, M.-P.; Ellouze, F.; Sfar, G.; Sfar, M.; van Loghem, E. Gm, Am and Km immunoglobulin allotypes of two populations in Tunisia. Hum. Genet. 1979, 50, 199–211. [Google Scholar] [CrossRef]
- Lefranc, G.; Lefranc, M.-P. The Immunoglobulin FactsBook; Academic Press: London, UK, 2001; pp. 1–458. [Google Scholar]
- Ropartz, C.; Rivat, L.; Rousseau, P.Y.; Baitsch, H.; van Loghem, J. The Gm and Inv systems in Europe. Acta Genet. Stat. Med. 1963, 13, 109–123. [Google Scholar]
- Ropartz, C.; Rousseau, P.Y.; Rivat, L. Les groupes de gamma-globulines Gm et Inv: Etude génétique et anthropologique. Bull. Soc. Anthropol. Paris 1963, 4, 458–469. [Google Scholar]
- Steinberg, A.G.; Matsumoto, H. Studies on the Gm, Inv, Hp and Tf serum factors of Japanese populations and families. Hum. Biol. 1964, 36, 77–85. [Google Scholar]
- Taleb, N.; Ruffie, J. Hémotypologie des populations jordaniennes. Bull. Mém. Soc. Anthrop. Paris 1968, 3, 269–282. [Google Scholar]
- Ropartz, C.; Rivat, L.; Rousseau, P.Y.; Lauridsen, U.B.; Persson, I. A survey of 9 Gm-factors, the Inv and the ISf systems in Danes. Hum. Hered. 1970, 20, 275–280. [Google Scholar] [CrossRef]
- Jenkins, T.; Zoutendyk, A.; Steinberg, A.G. Gammaglobulin groups (Gm and Inv) of various Southern African populations. Am. J. Phys. Anthropol. 1970, 32, 197–218. [Google Scholar] [CrossRef]
- Mayr, W.R.; Mickerts, D. Der menschliche Gammaglobulin-Polymorphismus. Acta Biol. Med. Ger. 1970, 25, 475–482. [Google Scholar]
- Bonné, B.; Godber, M.; Ashbel, S.; Mourant, A.E.; Tills, D. South-Sinai Beduin. A preliminary report on their inherited blood factors. Am. J. Phys. Anthropol. 1971, 34, 397–408. [Google Scholar] [CrossRef]
- Ropartz, C.; Rivat, L.; Rousseau, P.Y.; Legueult, L.C. Frequency of Gm, Inv and ISf phenotypes in the population of 4 Yugoslavian villages. Hum. Hered. 1972, 22, 508–518. [Google Scholar] [CrossRef]
- Salzano, F.M.; Steinberg, A.G.; Tepfenhart, M.A. Gm and Inv allotypes of Brazilian Cayapo Indians. Am. J. Hum. Genet. 1973, 25, 167–177. [Google Scholar]
- Steinberg, A.G. Contribution of the Gm and Inv allotypes to the characterization of human populations. Israel J. Med. Sci. 1973, 9, 1249–1256. [Google Scholar] [PubMed]
- Steinberg, A.G. Gm and Inv allotypes of some Sidamo Ethiopians. Am. J. Phys. Anthropol. 1973, 39, 403–408. [Google Scholar] [CrossRef] [PubMed]
- Wiebecke, D. Die frequenczen von Gm (1,2,3,5) und Inv (1) in der Bevölkerung der Bundesrepublik Deustchland. Humangenetik 1973, 18, 175–180. [Google Scholar] [CrossRef]
- Fraser, G.R.; Volkers, W.S.; Bernini, L.F.; van Loghem, E.; Meera Khan, P.; Nijenhuis, L.E. Gene frequencies in a Dutch population. Hum. Hered. 1974, 24, 435–448. [Google Scholar] [CrossRef] [PubMed]
- Daveau, M.; Rivat, L.; Langaney, A.; Afifi, N.; Bois, E.; Ropartz, C. Gm and Inv allotypes in French Guiana Indians. Hum. Hered. 1975, 25, 88–92. [Google Scholar] [CrossRef]
- Schanfield, M.S.; Gergely, J.; Fudenberg, H.H. Immunoglobulin allotypes of European populations. I. Gm and Km(Inv) allotypic markers in Hungarians. Hum. Hered. 1975, 25, 370–377. [Google Scholar] [CrossRef]
- Schanfield, M.S.; Herzog, P.; Fudenberg, H.H. Immunoglobulin allotypes of European populations. II. Gm, Am and Km(Inv) allotypic markers in Czechoslovakians. Hum. Hered. 1975, 25, 382–392. [Google Scholar] [CrossRef]
- Steinberg, A.G.; Jenkins, T.; Nurse, G.T.; Harpending, H.C. Gammaglobulin groups of the Khoisan peoples of Southern Africa: Evidence for polymorphism for a Gm1,5,13,14,21 haplotype among the San. Am. J. Hum. Genet. 1975, 27, 528–542. [Google Scholar]
- Lalouel, J.M.; Loiselet, J.; Lefranc, G.; Chaiban, D.; Chakhachiro, L.; Rivat, L.; Ropartz, C. Genetic differentiation among Lebanese communities. Acta Anthropog. 1976, 1, 15–33. [Google Scholar]
- Piazza, A.; van Loghem, E.; de Lange, G.; Curtoni, E.S.; Ulizzi, L.; Terrenato, L. Immunoglobulin allotypes in Sardinia. Am. J. Hum. Genet. 1976, 28, 77–86. [Google Scholar]
- Gershowitz, H.; Neel, J.V. The immunoglobulin allotypes (Gm and Km) of twelve Indian tribes of Central and South America. Am. J. Phys. Anthropol. 1978, 49, 289–301. [Google Scholar] [CrossRef]
- Rivat, L.; Rivat, C.; Cook, C.E.; Steinberg, A.G. Gm(28). Un nouvel allotype du système Gm présent sur les IgG3: Intérêt particulier de son étude dans les populations négroides. Ann. Immunol. Inst. Pasteur 1978, 129, 33–45. [Google Scholar]
- Steinberg, A.G.; Cook, C.E. The Distribution of the Human Immunoglobulin Allotypes; Oxford University Press: Oxford, UK, 1981. [Google Scholar]
- Chaabani, H.; Helal, A.N.; van Loghem, E.; Langaney, A.; Benammar Elgaaied, A.; Rivat Peran, L.; Lefranc, G. Genetic study of Tunisian Berbers. I. Gm, Am and Km immunoglobulin allotypes and ABO blood groups. J. Immunogenet. 1984, 11, 107–113. [Google Scholar] [CrossRef]
- de Lange, G.; Zhong, F.M.; Henke, J.; Feng, Z.C.; Bernhardt, R.; van Leeuwen, F.; van Eede, P. Immunoglobulin allotypes in a Chinese population: Comparison of haplotype frequencies with other Asian groups. J. Immunogenet. 1985, 12, 191–195. [Google Scholar] [CrossRef]
- Van Loghem, E. Immunoglobulin markers. In African Pygmies; Cavalli-Sforza, L.L., Ed.; Academic Press, Inc.: London, UK, 1986; Chapter 14; p. 201. [Google Scholar]
- Helal, A.N.; Rivat-Peran, L.; van Loghem, E.; de Lange, G.; Langaney, A.; Lefranc, G. Further contribution of common Gm-Am haplotypes and Km alleles in the characterization of the Tunisian population. Exp. Clin. Immunogenet. 1988, 5, 1–14. [Google Scholar]
- Helal, A.N.; de Lange, G.; van Loghem, E.; Lefranc, G. Uncommon Gm haplotypes in the Tunisian population: Further contribution to the genetics of the IgG immunoglobulins. Exp. Clin. Immunogenet. 1988, 5, 24–38. [Google Scholar]
- Soua, Z.; Ghanem, N.; Ben Salem, M.; Lefranc, G.; Lefranc, M.-P. Frequencies of the human immunoglobulin IGHA2*M1 and IGHA2*M2 alleles corresponding to the A2m(1) and A2m(2) allotypes in the French, Lebanese, Tunisian and Black African populations. Nucleic Acids Res. 1989, 17, 3625. [Google Scholar] [CrossRef]
- Zhao, T.M.; Lee, T.D. Gm and Km allotypes in 74 Chinese populations: A hypothesis of the origin of the Chinese nation. Hum. Genet. 1989, 83, 101–110. [Google Scholar] [CrossRef]
- Blanc, M.; Sanchez-Mazas, A.; Van Blyenburgh, N.H.; Sevin, A.; Pison, G.; Langaney, A. Interethnic genetic differentiation: Gm polymorphism in eastern Senegal. Am. J. Hum. Genet. 1990, 46, 383–392. [Google Scholar]
- Sukernik, R.I.; Osipova, L.P.; Schanfield, M.S. Distribution of GM allotypes and deleted IGHG1 haplotypes in the Sel’kups in comparison to the Forest Nentsi of northwestern Siberia. Exp. Clin. Immunogenet. 1992, 9, 15–23. [Google Scholar]
- Schanfield, M.S. Immunoglobulin allotypes (GM and KM) indicate multiple founding populations of Native Americans: Evidence of at least four migrations to the New World. Hum. Biol. 1992, 64, 381–402. [Google Scholar] [PubMed]
- Yacoubi Loveslati, B.; Sanchez-Mazas, A.; Ennafaa, H.; Marrakchi, R.; Dugoujon, J.-M.; Lefranc, M.-P.; Ben Ammar Elgaaied, A. A study of Gm allotypes and immunoglobulin heavy gamma chain IGHG genes in Berbers, Arabs and sub-Saharan Africans from Jerba Island, Tunisia. Eur. J. Immunogenet. 2001, 28, 531–538. [Google Scholar] [CrossRef] [PubMed]
- Geha, R.S.; Malakian, A.; Lefranc, G.; Chaiban, D.; Serre, J.L. Immunologic reconstitution in severe combined immunodeficiency following transplantation with parental bone marrow. Pediatrics 1976, 58, 451–455. [Google Scholar] [CrossRef]
- Van Loghem, E.; Natvig, J.B. Uncommon Gm gene complexes. Vox Sang. 1970, 18, 421–434. [Google Scholar] [CrossRef] [PubMed]
- Van Loghem, E.; Natvig, J.B.; Matsumoto, H. Genetic markers of immunoglobulins in Japanese families. Inheritance of associated markers belonging to one IgA and three IgG subclasses. Ann. Hum. Genet. 1970, 33, 351–359. [Google Scholar] [CrossRef]
- Lefranc, G.; Dumitresco, S.M.; Salier, J.P.; Rivat, L.; de Lange, G.; van Loghem, E.; Loiselet, J. Familial lack of the IgG3 subclass: Gene elimination or turning off expression and neutral evolution in the immune system. J. Immunogenet. 1979, 6, 215–221. [Google Scholar] [CrossRef]
- Salier, J.P.; Rivat, L.; Daveau, M.; Lefranc, G.; Breton, P.; De Menibus, C.H.; Henocq, A.; Fudenberg, H.H. Quantitative studies of Gm allotypes. V. Simultaneous presence of latent Gm allotypes and deficient Gm genes in a family with hypogammaglobulinaemic probands. J. Immunogenet. 1980, 7, 123–135. [Google Scholar] [CrossRef]
- Van Loghem, E.; Sukernik, R.I.; Osipova, L.P.; Zegers, B.J.M.; Matsumoto, H.; De Lange, G.; Lefranc, G. Gene deletion and gene duplication within the cluster of human heavy chain genes. Selective absence of IgG sub-classes. J. Immunogenet. 1980, 7, 285–299. [Google Scholar] [CrossRef]
- Lefranc, M.-P. Les Allotypes Gm, Am et Km des Immunoglobulines Humaines Dans Deux Échantillons de la Population Tunisienne (Mahdia et Sfax): Contribution à la Connaissance Séro-Anthropologique de Cette Population et à la Génétique Des Immunoglobulines. Ph.D. Thesis, Université Paris Sud, Orsay, France, 1980; pp. 1–108. (In French). [Google Scholar]
- Lefranc, G.; Lefranc, M.-P.; Helal, A.N.; Boukef, K.; Chaabani, H.; Gandoura, M.S.; van Loghem, E. Unusual heavy chains of human IgG immunoglobulins: Rearrangements of the CH domain exons. J. Immunogenet. 1982, 9, 1–9. [Google Scholar] [CrossRef]
- Van Loghem, E.; de Lange, G.; van Leeuwen, A.M.; van Eede, P.H.; Nijenhuis, L.E.; Lefranc, M.-P.; Lefranc, G. Human IgG allotypes co-occurring in more than one IgG subclass. Vox Sang. 1982, 43, 301–309. [Google Scholar] [CrossRef]
- Lefranc, M.-P.; Lefranc, G.; Rabbitts, T.H. Inherited deletion of immunoglobulin heavy chain constant region genes in normal human individuals. Nature 1982, 300, 760–762. [Google Scholar] [CrossRef]
- Lefranc, M.-P.; Lefranc, G.; de Lange, G.; Out, T.A.; van den Broek, P.J.; van Nieuwkoop, J.; Radl, J.; Helal, A.N.; Chaabani, H.; Van Loghem, E.; et al. Instability of the human immunoglobulin heavy chain constant region locus indicated by different inherited chromosomal deletions. Mol. Biol. Med. 1983, 1, 207–217. [Google Scholar]
- Lefranc, G.; Chaabani, H.; van Loghem, E.; Lefranc, M.-P.; de Lange, G.; Helal, A.N. Simultaneous absence of the human IgG1, IgG2, IgG4 and IgA1 subclasses: Immunological and immunogenetical considerations. Eur. J. Immunol. 1983, 13, 240–244. [Google Scholar] [CrossRef]
- Flanagan, J.G.; Lefranc, M.-P.; Rabbitts, T.H. Mechanisms of divergence and convergence of the human immunoglobulin alpha1 and alpha2 constant region gene sequences. Cell 1984, 36, 681–688. [Google Scholar] [CrossRef]
- Lefranc, M.-P.; Rabbitts, T.H. Human immunoglobulin heavy chain A2 gene allotype determination by restriction fragment length polymorphism. Nucleic Acids Res. 1984, 12, 1303–1311. [Google Scholar] [CrossRef] [Green Version]
- Lefranc, M.-P. Recombinaisons, Délétions et Conversions de Gènes de la Région Constante Des Chaînes Lourdes Des Immunoglobulines Humaines. Ph.D. Thesis, Université Montpellier 2, Montpellier, France, 1984. (In French). [Google Scholar]
- Lefranc, M.-P.; Helal, A.N.; de Lange, G.; Chaabani, H.; van Loghem, E.; Lefranc, G. Gene conversion in human immunoglobulin γ locus shown by unusual location of IgG allotypes. FEBS Lett. 1986, 196, 96–102. [Google Scholar] [CrossRef] [Green Version]
- Huck, S.; Fort, P.; Crawford, D.H.; Lefranc, M.-P.; Lefranc, G. Sequence of a human immunoglobulin γ3 heavy chain constant region gene: Comparison with the other human Cγ genes. Nucleic Acids Res. 1986, 14, 1779–1789. [Google Scholar] [CrossRef]
- Lefranc, M.-P.; Lefranc, G. Human immunoglobulin heavy-chain multigene deletions in healthy individuals. FEBS Lett. 1987, 213, 231–237. [Google Scholar] [CrossRef] [Green Version]
- Huck, S.; Lefranc, G.; Lefranc, M.-P. A human immunoglobulin IGHG3 allele (Gmb0,b1,c3,c5,u) with an IGHG4 converted region and three hinge exons. Immunogenetics 1989, 30, 250–257. [Google Scholar] [CrossRef]
- Keyeux, G.; Lefranc, G.; Lefranc, M.-P. A multigene deletion in the human IGH constant region locus involves highly homologous hot spots of recombination. Genomics 1989, 5, 431–441. [Google Scholar] [CrossRef]
- Lefranc, M.-P.; Hammarström, L.; Smith, C.I.E.; Lefranc, G. Gene deletions in the human immunoglobulin heavy chain constant region locus: Molecular and immunological analysis. Immunodefic. Rev. 1991, 2, 265–281. [Google Scholar] [PubMed]
- Bensmana, M.; Chuchana, P.; Lefranc, G.; Lefranc, M.-P. Sequence of the CH1 and hinge-CH2 exons of the human immunoglobulin IGHA2 A2m(2) allele: Comparison with the nonallelic and allelic IGHA genes. Cytogenet. Cell Genet. 1991, 56, 128. [Google Scholar] [CrossRef] [PubMed]
- Lefranc, M.-P.; Hammarström, L.; Smith, C.I.E.; Lefranc, G. Gene deletions in the human immunoglobulin heavy chain constant region locus: Molecular and immunological analysis. In Immunodeficiencies; Rosen, F.S., Seligmann, M., Eds.; Harwood Academic Publishers: Newark, NJ, USA, 1993; Chapter 5; pp. 99–109. [Google Scholar]
- Wiebe, V.; Helal, A.; Lefranc, M.-P.; Lefranc, G. Molecular analysis of the T17 immunoglobulin CH multigene deletion (del A1-GP-G2-G4-E). Hum. Genet. 1994, 93, 520–528. [Google Scholar] [CrossRef] [PubMed]
- Dard, P.; Huck, S.; Frippiat, J.P.; Lefranc, G.; Langaney, A.; Lefranc, M.-P.; Sanchez-Mazas, A. The IGHG3 gene shows a structural polymorphism characterized by different hinge lengths: Sequence of a new 2-exon hinge gene. Hum. Genet. 1997, 99, 138–141. [Google Scholar] [CrossRef] [PubMed]
- Dard, P.; Lefranc, M.-P.; Osipova, L.; Sanchez-Mazas, A. DNA sequence variability of IGHG3 alleles associated to the main G3m haplotypes in human populations. Eur. J. Hum. Genet. 2001, 9, 765–772. [Google Scholar] [CrossRef] [Green Version]
- Flanagan, J.G.; Rabbitts, T.H. Arrangement of human immunoglobulin heavy chain constant region genes implies evolutionary duplication of a segment containing γ, ε and α genes. Nature 1982, 300, 709–713. [Google Scholar] [CrossRef]
- Rabbitts, T.H.; Flanagan, J.G.; Lefranc, M.-P. Flexibility and change within the human immunoglobulin gene locus. In Genetic Rearrangement; Chater, K.F., Cullis, C.A., Hopwood, D.A., Johnston, A.W.B., Woolhouse, H.W., Eds.; Croom Helm: London, UK, 1983; pp. 143–154. [Google Scholar]
- Ghanem, N.; Lefranc, M.-P.; Lefranc, G. Definition of the RFLP alleles in the human immunoglobulin IGHG gene locus. Eur. J. Immunol. 1988, 18, 1059–1065. [Google Scholar] [CrossRef]
- Ghanem, N.; Dugoujon, J.M.; Bensmana, M.; Huck, S.; Lefranc, M.-P.; Lefranc, G. Restriction fragment haplotypes in the human immunoglobulin IGHG locus and their correlation with the Gm polymorphism. Eur. J. Immunol. 1988, 18, 1067–1072. [Google Scholar] [CrossRef]
- Ghanem, N.; Dugoujon, J.M.; Lefranc, M.-P.; Lefranc, G. BstEII restriction fragment alleles and haplotypes of the human IGHG genes with reference to the BamHI/SacI RFLPs and to the Gm polymorphism. Exp. Clin. Immunogenet. 1989, 6, 39–54. [Google Scholar]
- Ghanem, N.; Bensmana, M.; Dugoujon, J.M.; Constans, J.; Lefranc, M.-P.; Lefranc, G. BamHI and SacI RFLPs of the human immunoglobulin IGHG genes with reference to the Gm polymorphism in African people. Evidence for a major polymorphism. Hum. Genet. 1989, 83, 37–4418. [Google Scholar] [CrossRef]
- Hammarström, L.; Ghanem, N.; Smith, C.I.E.; Lefranc, G.; Lefranc, M.-P. RFLP of human immunoglobulin genes. Exp. Clin. Immunogenet. 1990, 7, 7–19. [Google Scholar] [PubMed]
- Dard, P.; Sanchez-Mazas, A.; Dugoujon, J.M.; de Lange, G.; Langaney, A.; Lefranc, M.-P.; Lefranc, G. DNA analysis of the immunoglobulin IGHG loci in a Mandenka population from eastern Senegal: Correlation with Gm haplotypes and hypotheses for the evolution of the Ig CH region. Hum. Genet. 1996, 98, 36–47. [Google Scholar] [CrossRef] [PubMed]
- Osipova, L.P.; Posukh, O.L.; Wiebe, V.P.; Miyazaki, T.; Matsumoto, H.; Lefranc, G.; Lefranc, M.-P. BamHI-SacI RFLP and Gm analysis of the immunoglobulin IGHG genes in the Northern Selkups (west Siberia): New haplotypes with deletion, duplication and triplication. Hum. Genet. 1999, 105, 530–541. [Google Scholar] [CrossRef]
- Lefranc, M.-P. Antibody nomenclature: From IMGT-ONTOLOGY to INN definition. MAbs 2011, 3, 1–2. [Google Scholar] [CrossRef] [Green Version]
- Jefferis, R.; Lefranc, M.-P. Human immunoglobulin allotypes: Possible implications for immunogenicity. MAbs 2009, 1, 332–338. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Magdelaine-Beuzelin, C.; Vermeire, S.; Goodall, M.; Baert, F.; Noman, M.; Van Assche, G.; Ohresser, M.; Degenne, D.; Dugoujon, J.M.; Jefferis, R.; et al. IgG1 heavy chain-coding gene polymorphism (G1m allotypes) and development of antibodies-to-infliximab. Pharmacogenet. Genom. 2009, 19, 383–387. [Google Scholar] [CrossRef] [Green Version]
- Giudicelli, V.; Lefranc, M.-P. Ontology for Immunogenetics: IMGT-ONTOLOGY. Bioinformatics 1999, 15, 1047–1054. [Google Scholar] [CrossRef] [Green Version]
- Duroux, P.; Kaas, Q.; Brochet, X.; Lane, J.; Ginestoux, C.; Lefranc, M.-P.; Giudicelli, V. IMGT-Kaleidoscope, the Formal IMGT-ONTOLOGY paradigm. Biochimie 2008, 90, 570–583. [Google Scholar] [CrossRef] [Green Version]
- Lefranc, M.-P. WHO-IUIS Nomenclature Subcommittee for Immunoglobulins and T cell receptors report. Immunogenetics 2007, 59, 899–902. [Google Scholar] [CrossRef]
- Lefranc, M.-P. WHO-IUIS Nomenclature Subcommittee for Immunoglobulins and T cell receptors report. In Proceedings of the 13th International Congress of Immunology, Rio de Janeiro, Brazil, 25–27 August 2007; pp. 461–463. [Google Scholar]
- Lefranc, M.-P. Immunoglobulin (IG) and T cell receptor genes (TR): IMGT® and the birth and rise of immunoinformatics. Front. Immunol. 2014, 5, 22. [Google Scholar] [CrossRef] [Green Version]
- Lefranc, M.-P.; Giudicelli, V.; Duroux, P.; Jabado-Michaloud, J.; Folch, G.; Aouinti, S.; Carillon, E.; Duvergey, H.; Houles, A.; Paysan-Lafosse, T.; et al. IMGT®, the international ImMunoGeneTics information system® 25 years on. Nucleic Acids Res. 2015, 43, D413–D422. [Google Scholar] [CrossRef]
- Van Loghem, E.; Aalberse, R.C.; Matsumoto, H. A genetic marker of human IgE heavy chains, Em(1). Vox Sang. 1984, 46, 195–206. [Google Scholar] [CrossRef]
- De Lange, G. Monoclonal Antibodies against Human Immunoglobulin Allotypes. Ph.D. Thesis, University of London, London, UK, 1988; pp. 1–175. [Google Scholar]
- Ghanem, N.; Dariavach, P.; Bensmana, M.; Chibani, J.; Lefranc, G.; Lefranc, M.-P. Polymorphism of immunoglobulin lambda constant region genes in populations from France, Lebanon and Tunisia. Exp. Clin. Immunogenet. 1988, 5, 186–195. [Google Scholar]
- Lefranc, M.-P.; Lefranc, G. Les Immunoglobulines humaines. In L’hématologie de Bernard Dreyfus; Breton-Gorius, J., Reyes, F., Rochant, H., Rosa, J., Vernant, J.P., Eds.; Médecine-Sciences Flammarion: Paris, France, 1992; Chapter 20; pp. 197–254. [Google Scholar]
- Lefranc, M.-P.; Pallarès, N.; Frippiat, J.-P. Allelic polymorphisms and RFLP in the human immunoglobulin lambda light chain locus. Hum. Genet. 1999, 104, 361–369. [Google Scholar] [CrossRef]
- Lefranc, M.-P.; Lefranc, G. Immunoglobulin lambda (IGL) genes of human and mouse. In Molecular Biology of B Cells; Honjo, T., Alt, F.W., Neuberger, M.S., Eds.; Academic Press: London, UK; Elsevier Science: Amsterdam, The Netherlands, 2004; pp. 37–59. [Google Scholar]
- Gold, E.R.; Fudenberg, H.H. Chromic chloride: A coupling reagent for passive hemagglutination reactions. J. Immunol. 1967, 99, 859–866. [Google Scholar] [CrossRef]
- Zelaschi, D.; Newby, C.; Parsons, M.; van West, B.; Cavalli-Sforza, L.L.; Herzenberg, L.A.; Herzenberg, L.A. Human immunoglobulin allotypes: Previously unrecognized determinants and alleles defined with monoclonal antibodies. Proc. Natl. Acad. Sci. USA 1983, 80, 3762–3766. [Google Scholar] [CrossRef]
- Kurth, J.H.; Bowcock, A.M.; Erlich, H.A.; Nevo, S.; Cavalli-Sforza, L.L. Km typing with PCR: Application to population screening. Am. J. Hum. Genet. 1991, 48, 613–620. [Google Scholar]
- Balbin, M.; Grubb, A.; Abrahamson, M.; Grubb, R. Determination of allotypes G1m (f) and G1m (z) at the genomic level by subclass-specific amplification of DNA and use of allele-specific probes. Exp. Clin. Immunogenet. 1991, 8, 88–95. [Google Scholar]
- Balbin, M.; Grubb, A.; de Lange, G.G.; Grubb, R. DNA sequences specific for Caucasian G3m (b) and (g) allotypes: Allotyping at the genomic level. Immunogenetics 1994, 39, 187–193. [Google Scholar] [CrossRef]
- Brusco, A.; de Lange, G.G.; Boccazzi, C.; Carbonara, A.O. Molecular characterization of G2m (n+) and G2m (n−) allotypes. Immunogenetics 1995, 42, 414–417. [Google Scholar] [CrossRef]
- Hougs, L.; Svejgaard, A.; Barington, T. The first constant-domain (CH1) exon of human IGHG2 is polymorphic and in strong linkage disequilibrium with the (CH2) exon polymorphism encoding the G2m(n+) allotype in Caucasians. Immunogenetics 2001, 52, 242–248. [Google Scholar] [CrossRef] [PubMed]
- Frangione, B.; Franklin, E.C.; Fudenberg, H.H.; Koshland, M.E. Structural studies of human γG myeloma proteins of different antigenic subgroups and genetic specificities. J. Exp. Med. 1966, 124, 715–732. [Google Scholar] [CrossRef] [PubMed]
- Press, E.M.; Hogg, N.M. The amino-acid sequences of the Fd fragments of two human γ1 heavy chains. Biochem. J. 1970, 117, 641–660. [Google Scholar] [CrossRef] [PubMed]
- Burton, R.M.; Deutsch, H.F. The structure of peptides of Fc-fragments from γG-globulins of known allotypic specificity. Immunochemistry 1970, 7, 145–156. [Google Scholar] [CrossRef] [PubMed]
- Natvig, J.B.; Turner, M.W. Localization of Gm markers to different molecular regions of the Fc fragment. Clin. Exp. Immunol. 1971, 8, 685–700. [Google Scholar]
- Michaelsen, T.E.; Frangione, B.; Franklin, E.C. The amino acid sequence of a human immunoglobulin G3m(g) pFc’ fragment. J. Immunol. 1977, 119, 558–563. [Google Scholar] [CrossRef]
- Pardo, A.G.; Rosenwasser, E.S.; Frangione, B. The primary structure of a human immunoglobulin G2 (IgG2) pFc’fragment. J. Immunol. 1978, 121, 1040–1044. [Google Scholar] [CrossRef]
- Natvig, J.B.; Kunkel, H.G.; Joslin, F.G. Delineation of two antigenic markers, “non a” and “non g” related to the genetic antigens of human gamma globulins. J. Immunol. 1969, 102, 611–617. [Google Scholar] [CrossRef]
- Kunkel, H.G.; Joslin, F.G.; Penn, G.M.; Natvig, J.B. Genetic variants of γG4 globulin. A unique relationship to other classes of γG globulin. J. Exp. Med. 1970, 13, 508–520. [Google Scholar] [CrossRef]
- Van Loghem, E.; de Lange, G. ‘non-b’, Antigenic determinant of IgG. Vox Sang. 1972, 22, 193–199. [Google Scholar] [CrossRef]
- Gaarder, P.I.; Natvig, J.B. Two new antigens of human IgG, “non b0” and “non b1”, related to the Gm system. J. Immunol. 1972, 108, 617–621. [Google Scholar] [CrossRef]
- Van Loghem, E.; de Lange, G. The first example of an isoallotype of human IgG located on the Fd fragment. Scand. J. Immunol. 1976, 5, 1015–1019. [Google Scholar] [CrossRef]
- Van Loghem, E.; de Lange, G.; Koistinen, J. The first isoallotype of human IgA proteins. An antigenic determinant occurring as allotype in the IgA2 subclass and as isotype in the IgA1 subclass. Scand. J. Immunol. 1976, 5, 161–164. [Google Scholar]
- Lefranc, M.-P.; Pommié, C.; Kaas, Q.; Duprat, E.; Bosc, N.; Guiraudou, D.; Jean, C.; Ruiz, M.; Da Piédade, I.; Rouard, M.; et al. IMGT unique numbering for immunoglobulin and T cell receptor constant domains and Ig superfamily C-like domains. Dev. Comp. Immunol. 2005, 29, 185–203. [Google Scholar] [CrossRef]
- Giudicelli, V.; Chaume, D.; Lefranc, M.-P. IMGT/GENE-DB: A comprehensive database for human and mouse immunoglobulin and T cell receptor genes. Nucleic Acids Res. 2005, 33, D256–D261. [Google Scholar] [CrossRef] [Green Version]
- Kaas, Q.; Ruiz, M.; Lefranc, M.-P. IMGT/3Dstructure-DB and IMGT/StructuralQuery, a database and a tool for immunoglobulin, T cell receptor and MHC structural data. Nucleic Acids Res. 2004, 32, D208–D210. [Google Scholar] [CrossRef]
- Ehrenmann, F.; Kaas, Q.; Lefranc, M.-P. IMGT/3Dstructure-DB and IMGT/DomainGapAlign: A database and a tool for immunoglobulins or antibodies, T cell receptors, MHC, IgSF and MhcSF. Nucleic Acids Res. 2010, 38, D301–D307. [Google Scholar] [CrossRef]
- Ruiz, M.; Lefranc, M.-P. IMGT gene identification and Colliers de Perles of human immunoglobulin with known 3D structures. Immunogenetics 2002, 53, 857–883. [Google Scholar] [CrossRef]
- Kaas, Q.; Ehrenmann, F.; Lefranc, M.-P. IG, TR and IgSf, MHC and MhcSF: What do we learn from the IMGT Colliers de Perles? Brief. Funct. Genom. Proteom. 2007, 6, 253–264. [Google Scholar] [CrossRef] [Green Version]
- Pommié, C.; Levadoux, S.; Sabatier, R.; Lefranc, G.; Lefranc, M.-P. IMGT standardized criteria for statistical analysis of immunoglobulin V-REGION amino acid properties. J. Mol. Recognit. 2004, 17, 17–32. [Google Scholar] [CrossRef]
- van Loghem, E. Formal genetics of the immunoglobulin systems. Ann. N. Y. Acad. Sci. 1971, 190, 136–149. [Google Scholar] [CrossRef] [PubMed]
- Wang, A.C.; Shuster, J.; Fudenberg, H.H. Evolutionary origin of the Gm”a” peptide of immunoglobulins. J. Mol. Biol. 1969, 41, 83–86. [Google Scholar] [CrossRef] [PubMed]
- Cook, C.E.; Steinberg, A.G. An amino acid substitution in the γ1 chain of human immunoglobulin G associated with the Gm (2) allotype. Mol. Immunol. 1979, 16, 555–558. [Google Scholar] [CrossRef] [PubMed]
- Wolfenstein-Todel, C.; Frangione, B.; Prelli, F.; Franklin, E.C. The amino acid sequence of “heavy chain disease” protein ZUC. Structure of the Fc fragment of immunoglobulin G3. Biochem. Biophys. Res. Commun. 1976, 71, 907–914. [Google Scholar] [CrossRef] [PubMed]
- Frangione, B.; Rosenwasser, E.; Prelli, F.; Franklin, E.C. Primary structure of human γ3 immunoglobulin deletion mutant: γ3 heavy-chain disease protein Wis. Biochemistry 1980, 19, 4304–4308. [Google Scholar] [CrossRef]
- Alexander, A.; Steinmetz, M.; Barritault, D.; Frangione, B.; Franklin, E.C.; Hood, L.; Buxbaum, J.N. gamma Heavy chain disease in man: cDNA sequence supports partial gene deletion model. Proc. Natl. Acad. Sci. USA 1982, 79, 3260–3264. [Google Scholar] [CrossRef]
- Recht, B.; Frangione, B.; Franklin, E.; van Loghem, E. Structural studies of a human γ3 myeloma protein (GOE) that binds Staph. Protein A. J. Immunol. 1981, 127, 917–923. [Google Scholar] [CrossRef]
- Matsumoto, H.; Ito, S.; Miyazaki, T.; Ohta, T. Structural studies of a human γ3 myeloma protein (JIR) bearing the allotypic marker Gm(st). J. Immunol. 1983, 131, 1865–1870. [Google Scholar] [CrossRef]
- Matsumoto, H.; Ito, S.; Miyazaki, T.; Kawai, N. Structural studies of another human IgG3 myeloma protein (Kam) carrying the allotypic markers Gm(s,t) and its alteration induced by chemical modification. In Advances in Forensic Haemogenetics; Brinkmann, B., Henningsen, K., Eds.; Springer: Berlin/Heidelberg, Germany, 1986; Volume I, p. 153. [Google Scholar]
- Abel, C.A.; Despont, J.P. An amino acid deletion associated with the IgG4b allotype of human IgG4 myeloma proteins. J. Immunogenet. 1974, 1, 79–82. [Google Scholar] [CrossRef]
- Tsuzukida, Y.; Wang, C.C.; Putnam, F.W. Structure of the A2m(1) allotype of human IgA. A recombinant molecule. Proc. Natl. Acad. Sci. USA 1979, 76, 1104–1108. [Google Scholar] [CrossRef]
- Toraño, A.; Putnam, F.W. Complete amino acid sequence of the alpha 2 heavy chain of a human IgA2 immunoglobulin of the A2m (2) allotype. Proc. Natl. Acad. Sci. USA 1978, 75, 966–969. [Google Scholar] [CrossRef]
- Liu, Y.S.; Low, T.L.; Infante, A.; Putnam, F.W. Complete covalent structure of a human IgA1 immunoglobulin. Science 1976, 193, 1017–1020. [Google Scholar] [CrossRef]
- Lefranc, M.-P.; Lefranc, G. Immunoglobulins or Antibodies: IMGT® Bridging Genes, Structures and Functions. Biomedicines 2020, 8, 319. [Google Scholar] [CrossRef]
- Lefranc, M.-P.; Lefranc, G. IMGT® Homo sapiens IG and TR loci, gene order, CNV and haplotypes: New concepts as a paradigm for jawed vertebrates genome assemblies. Biomolecules 2022, 12, 381. [Google Scholar] [CrossRef]
- Baglioni, C.; Alescio Zonta, L.; Cioli, D.; Carbonara, A. Allelic antigenic factor Inv(a) of the light chains of human immunoglobulins: Chemical basis. Science 1966, 152, 1517–1519. [Google Scholar] [CrossRef]
- Steinberg, A.G.; Milstein, C.P.; McLaughlin, C.L.; Solomon, A. Structural studies of an Inv (1, −2) kappa light chain. Immunogenetics 1974, 2, 108–117. [Google Scholar] [CrossRef]
- Milstein, C.P.; Steinberg, A.G.; McLaughlin, C.L.; Solomon, A. Amino acid sequence change associated with genetic marker Inv(2) of human immunoglobulin. Nature 1974, 248, 160–161. [Google Scholar] [CrossRef]
- Carter, P.; Presta, L.; Gorman, C.M.; Ridgway, J.B.; Henner, D.; Wong, W.L.; Rowland, A.M.; Kotts, C.; Carver, M.E.; Shepard, H.M. Humanization of an anti-p185HER2 antibody for human cancer therapy. Proc. Natl. Acad. Sci. USA 1992, 89, 4285–4289. [Google Scholar] [CrossRef] [PubMed]
- Goetze, A.M.; Zhang, Z.; Liu, L.; Jacobsen, F.W.; Flynn, G.C. Rapid LC-MS screening for IgG Fc modifications and allelic variants in blood. Mol. Immunol. 2011, 49, 338–352. [Google Scholar] [CrossRef] [PubMed]
- Dechavanne, C.; Guillonneau, F.; Chiappetta, G.; Sago, L.; Lévy, P.; Salnot, V.; Guitard, E.; Ehrenmann, F.; Cédric Broussard, C.; Chafey, P.; et al. Mass spectrometry detection of G3m and IGHG3 alleles and follow-up of differential mother and neonate IgG3. PLoS ONE 2012, 7, e46097. [Google Scholar] [CrossRef]
- Dambrun, M.; Dechavanne, C.; Emmanuel, A.; Aussenac, F.; Leduc, M.; Giangrande, C.; Vinh, J.; Dugoujon, J.-M.; Lefranc, M.-P.; Guillonneau, F.; et al. Human immunoglobulin heavy gamma chain polymorphisms: Molecular confirmation of proteomic assessment. Mol. Cell. Proteom. 2017, 16, 824–839. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lefranc, M.-P.; Lefranc, G. IMGT® nomenclature of engineered IGHG variants involved in antibody effector properties and formats. Antibodies 2022, 11, 65. [Google Scholar] [CrossRef]
Localization a | Nomenclature | |||
---|---|---|---|---|
IG Heavy Chain | Domain | WHO/IMGT Nomenclature b | Previous Designation | |
H-GAMMA1 | CH3 | G1m1 | G1m(a) | Grubb 1956 [3]; Grubb and Laurell 1956 [4] |
CH3 | G1m2 | G1m(x) | Harboe and Lundevall 1959 [5] | |
CH1 | G1m3 | G1m(f) | Steinberg and Wilson 1963 [6]; Gold et al., 1965 [7,8] | |
CH1 | G1m17 | G1m(z) | Litwin and Kunkel 1966 [9] | |
CH3 | G1m27 c | van Loghem et al., 1982 [80] | ||
CH3 | G1m28 c | van Loghem et al., 1982 [80] | ||
H-GAMMA2 | CH2 | G2m23 | G2m(n) | Kunkel et al., 1966 [10] |
H-GAMMA3 | CH3 | G3m5 | G3m(b1) | Harboe 1959 [11] |
CH3 | G3m6 | G3m(c3) | Steinberg et al., 1960 [12] | |
CH3 | G3m10 | G3m(b5) | Ropartz et al.,1963 [13] | |
CH3 | G3m11 | G3m(b0) | Ropartz et al., 1963 [13] | |
CH3 | G3m13 | G3m(b3) | Steinberg and Goldblum 1965 [14] | |
CH3 | G3m14 | G3m(b4) | Steinberg and Goldblum 1965 [14] | |
CH3 | G3m15 | G3m(s) | Martensson et al., 1966 [15] | |
CH2 | G3m16 | G3m(t) | Martensson et al., 1966 [15] | |
CH2 | G3m21 | G3m(g1) | Natvig 1966 [16] | |
CH3 | G3m24 | G3m(c5) | van Loghem and Martensson 1967 [17] | |
CH3 | G3m26 | G3m(u) | van Loghem and Grobbelaar 1971 [18] | |
CH3 | G3m27 d | G3m(v) d | Schanfield and Fudenberg 1974 [19] | |
CH3 | G3m28 d | G3m(g5) d | Blanc et al., 1976 [20] | |
H-ALPHA2 | CH1 | A2m1 | A2m1 | Vyas and Fudenberg 1969 [22]; Kunkel et al., 1969 [23] |
CH1 | A2m2 | A2m2 | van Loghem et al., 1973 [24] | |
CH3 | A2m3 e | |||
IG light chain | Domain | WHO/IMGT nomenclature b | Previous designation | |
L-KAPPA | C-KAPPA | Km1 | Km1 | Ropartz et al., 1962 [26] |
C-KAPPA | Km2 | Km2 | Ropartz et al., 1961 [25] | |
C-KAPPA | Km3 | Km3 | Steinberg et al., 1962 [27] |
Isoallotype Nomenclature | Distribution on IG Heavy Chains | ||||||
---|---|---|---|---|---|---|---|
WHO/IMGT | Previous Designation | Gamma1 | Gamma2 | Gamma3 | Gamma4 | Alpha1 | Alpha2 |
nG1m1 | nG1m(a) | allo | iso | iso | iso a | - | - |
nG1m17 | nG1m(z) | allo | - | iso | iso | - | - |
nG3m5 | nG3m(b1) | iso b | iso | allo | - | - | - |
nG3m11 | nG3m(b0) | iso | iso | allo | - | - | - |
nG3m21 | nG3m(g) | - | iso | allo | - | - | - |
nG4m(a) | nG4m(a) | iso | - | iso | allo | - | - |
nG4m(b) | nG4m(b) | - | iso | - | allo | - | - |
nA2m3 c | nA2m(2) | - | - | - | - | iso | allo |
G1m Allotypes and Isoallotypes | Amino Acid Positions a | |||||||
---|---|---|---|---|---|---|---|---|
Domain | CH1 | CH3 b | ||||||
IMGT | 120 | 12 | 14 | 101 | 110 | 115 | 116 | |
Eu | 214 | 356 | 358 | 431 | ||||
G1m1 | Asp D12 | Leu L14 | ||||||
nG1m1 | Glu E12 | Met M14 | ||||||
G1m2 | Gly G110 | |||||||
G1m3 | Arg R120 + Ileu I103 | |||||||
G1m17 | Lys K120 | |||||||
nG1m17 | Arg R120 | |||||||
G1m27 b | Ileu 101 | |||||||
G1m28 b | Arg R115 | Tyr Y116 |
G1m Alleles b | IGHG1 Alleles | Amino Acid Positions a | |||||
---|---|---|---|---|---|---|---|
Domain | CH1 | CH3 | |||||
IMGT 103 | 120 | 12 | 14 | 101 | 110 | ||
Exon (82) | (97) | (16) | (18) | (91) | |||
Eu 199 | 214 | 356 | 358 | 431 | |||
G1m17/ nG1m17 c | G1m1/nG1m1 | G1m27/- | G1m2/- | ||||
G1m3 c | |||||||
G1m17,1 | IGHG1*01, IGHG1*02 | Ile I103 atc | Lys K120 aaa | Asp D12 gat | Leu L14 ctg | Val 101 gtc | Ala A110 gct |
G1m3 nG1m1, nG1m17 | IGHG1*03 | Ile I103 atc | Arg R120 aga | Glu E gag | Met M atg | Val 101 gtc | Ala A110 gct |
G1m17,1,27 | IGHG1*04 | Ile I103 atc | Lys K120 aaa | Asp D12 gat | Leu L14 ctg | Ile I101 atc | Ala A110 gct |
G1m17,1,2 | IGHG1*07 | Ile I103 atc | Lys K120 aaa | Asp D12 gat | Leu L14 ctg | Val 101 gtc | Gly G110 ggt |
G1m3,1 nG1m17 | IGHG1*08 | Ile I103 atc | Arg R120 aga | Asp D2 gat | Leu L14 ctg | Val 101 gtc | Ala A110 gct |
G1m17,1,28 b | IGHG1*05p c | Ile I103 (atc) | Lys K120 (aaa) | Asp D12 (gat) | Leu L14 (ctg) | Val 101 (gtc) | Ala A110 (gct) |
G1m17,1,27,28 b | IGHG1*06p c | Ile I103 (atc) | Lys K120 (aaa) | Asp D12 (gat) | Leu L14 (ctg) | Ileu I101 (atc) | Ala A110 (gct) |
G1m17 nG1m1 | IGHG1*09p c | Ile I103 (atc) | Lys K120 (aaa) | Glu E (gag) | Met M (atg) | Val 101 (gtc) | Ala A110 (gct) |
G2m Alleles | IGHG2 Alleles | Amino Acid Position a | |
---|---|---|---|
Domain | CH2 | ||
IMGT | 45.1 | ||
Exon | (52) | ||
Eu | 282 | ||
G2m23/G2m.. | |||
G2m23 | IGHG2*02 | Met M45.1 atg | |
G2m.. | IGHG2*01, IGHG2*03, IGHG2*04, IGHG2*05, IGHG2*06 | Val V45.1 gtg |
G3m Allotypes and Isoallotypes | Amino Acid Position a | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Domain | CH2 | CH3 | ||||||||
IMGT | 82 | 83 | 39 | 44 | 84 | 98 | 101 | 115 | 116 | |
Exon | (61) | (62) | (39) | (44) | (57) | (79) | (82) | (95) | (96) | |
Eu | 291 | 292 | 379 | 384 | 397 | 419 | 422 | 435 | 436 | |
G3m5 | Arg R cgc | Phe F ttc | ||||||||
nG3m5 | His H cac | Tyr Y tac | ||||||||
G3m6 | Ser S agc | Glu E gag | ||||||||
G3m10 | Ser S agc | Ileu I atc | ||||||||
G3m11 | Ser S agc | |||||||||
nG3m11 | Asn N aat | |||||||||
G3m13 | Ser S agc | Gln Q cag | ||||||||
G3m14 | Met M atg | Arg R cgc | Phe F ttc | |||||||
G3m15 | Met M atg | His H cac | Tyr Y tac | |||||||
G3m16 | Trp W tgg | |||||||||
G3m21 | Leu L ctg | |||||||||
nG3m21 | Pro P ccg | |||||||||
G3m24 | Ser S agc | Val V gtc | ||||||||
G3m26 | Arg R cgc | |||||||||
G3m27 | Ileu I atc | |||||||||
G3m28 | Arg R cgc | Tyr Y tac |
Most Prevalent G3m Alleles (WHO/IMGT Nomenclature) | Simplified Form |
---|---|
G3m5,10,11,13,14,26,27 | G3m5* |
G3m5,6,10,11,14,26,27 | G3m6* |
G3m5,6,11,24,26 | G3m24* |
G3m10,11,13,15,27 | G3m15* |
G3m10,11,13,15,16,27 | G3m16* |
G3m21,26,27,28 | G3m21* |
G3m Alleles and IGHG3 Alleles | Amino Acid Position a,b | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Domain | CH2 | CH3 | ||||||||
IMGT | 82 | 83 | 39 | 44 | 84 | 98 | 101 | 115 | 116 | |
Exon | (61) | (62) | (39) | (44) | (57) | (79) | (82) | (95) | (96) | |
Eu | 291 | 292 | 379 | 384 | 397 | 419 | 422 | 435 | 436 | |
G3m5* (G3m5,10,11,13,14,26,27) nG3m21 IGHG3*01, IGHG3*05, IGHG3*06, IGHG3*07, IGHG3*09, IGHG3*10, IGHG3*11, IGHG3*12 | Pro P ccg | Arg R cgg | Val V gtg | Ser S agc | Met M atg | Gln Qcag | Ileu Iatc | Arg R cgc | Phe F ttc | |
G3m6* (G3m5,6,10,11,14,26,27) nG3m21 IGHG3*13 | Pro P ccg | Arg R cgg | Val V gtg | Ser S agc | Met M atg | Glu Egag | Ileu Iatc | Arg R cgc | Phe F ttc | |
G3m24* (G3m5,6,11,24,26) nG3m21 IGHG3*03 | Pro P ccg | Arg R cgg | Val V gtg | Ser S agc | Val V gtg | Glu Egag | Val Vgtc | Arg R cgc | Phe F ttc | |
G3m15* (G3m10,11,13,15,27) nG3m5, nG3m21 IGHG3*17 | Pro P ccg | Arg R cgg | Met M atg | Ser S agc | Val V gtg | Gln Qcag | Ileu Iatc | His H cac | Tyr Y tac | |
G3m16* (G3m10,11,13,15,16,27) nG3m5, nG3m21 IGHG3*18, IGHG3*19 | Pro P ccg | Trp W tgg | Met M atg | Ser S agc | Val V gtg | Gln Qcag | Ileu Iatc | His H cac | Tyr Y tac | |
G3m21* (G3m21,26,27,28) nG3m11 IGHG3*14, IGHG3*15, IGHG3*16 | Leu L ctg | Arg R cgg | Val V gtg | Asn N aat | Met M atg | Gln Q cag | Ileu Iatc | Arg R cgc | Tyr Y tac |
G4m Alleles | IGHG4 Alleles | Amino Acid Positions a | |
---|---|---|---|
Domain | CH2 | ||
IMGT | 92 | ||
Exon | (79) | ||
Eu | 309 | ||
nG4m(a)/nG4m(b) | |||
nG4m(a) | IGHG4*01, IGHG4*03, IGHG4*04 | Leu L92 ctg | |
nG4m(b) | IGHG4*02 | Val V92 gtg |
A2m Alleles | IGHA2 Alleles | Amino Acid Positions a | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Domain | CH1 | CH3 | CH-S | |||||||
IMGT | 115 | 123 | 124 | 85.2 | 100 | 124 | 134 | 143 | ||
Exon | (93) | (101) | (102) | (70) | (87) | (110) | (117) | (126) | ||
Bur | 212 | 220 | 221 | |||||||
A2m1 nA2m3 b | IGHA2*01 | Pro P ccc | Cys C tgc | Pro P cca | Phe F ttc | Asp D gac | Leu L ttg | Val V gtc | Val V gtg | |
A2m2,3 b | IGHA2*02 | Ser S tcc | Cys C tgc | Arg R cga | Tyr Y tac | Glu E gag | Met M atg | Ile I atc | Ala A gcg | |
A2m2 nA2m3 b | IGHA2*03 | Ser S tcc | Cys C tgc | Arg R cga | Phe F ttc | Asp D gac | Leu L ttg | Val V gtc | Val V gtg |
Populations | Prevalent Gm Haplotypes a | ||
---|---|---|---|
Gm Haplotypes | Simplified Form b | Complete Description (WHO/IMGT Nomenclature) | |
Caucasoid | A | Gm5*;3;23 | Gm5,10,11,13,14,26,27;3;23 |
B | Gm5*;3;.. | Gm5,10,11,13,14,26,27;3;.. | |
Caucasoid and Mongoloid | C | Gm21*;17,1;.. | Gm21,26,27,28;17,1;.. |
D | Gm21*;17,1,2;.. | Gm21,26,27,28;17,1,2;.. | |
Negroid | E | Gm5*;17,1;.. | Gm5,10,11,13,14,26,27;17,1;.. (+G1m28) c |
F | Gm6*;17,1;.. | Gm5,6,10,11,14,26,27;17,1;.. (+G1m28) c | |
G c | Gm24*;17,1;.. | Gm5,6,11,24,26;17,1;.. (+G1m28) c | |
Khoisan d | H | Gm15*;17,1;.. | Gm10,11,13,15,27;17,1;.. |
Mongoloid | I | Gm16*;17,1;.. | Gm10,11,13,15,16,27;17,1;.. |
J | Gm5*;3,1;23 | Gm5,10,11,13,14,26,27;3,1;23 | |
K | Gm5*;3,1;.. | Gm5,10,11,13,14,26,27;3,1;.. |
Gm Phenotypes a | Deduced Gm Genotypes with Contributing Gm Haplotypes | Observed b |
---|---|---|
5,10,11,13,14,26,27;3;23 | A/A ou A/B | 117 |
5,10,11,13,14,26,27;3;.. | B/B | 7 |
5,10,11,13,14,21,26,27,28;1,3,17;23 | A/C | 93 |
5,10,11,13,14,21,26,27,28;1,3,17;.. | B/C | 17 |
5,10,11,13,14,26,27;1,3,17;23 | A/E | 45 |
5,10,11,13,14,26,27;1,3,17;.. | B/E | 8 |
5,6,10,11,13,14,24,26,27;1,3,17;23 | A/G | 3 |
5,6,10,11,13,14,24,26,27;1,3,17;.. | B/G | 1 |
5,6,10,11,13,14,26,27;1,3,17;23 | A/F | 4 |
21,26,27,28;1,17;23 | C/M | 2 |
21,26,27,28;1,17;.. | C/C | 18 |
5,10,11,13,14,21,26,27,28;1,17;23 | E/M | 2 |
5,10,11,13,14,21,26,27,28;1,17;.. | C/E | 13 |
5,10,11,13,14,21,26,27,28;1,2,3,17;23 | A/D | 17 |
5,10,11,13,14,21,26,27,28;1,2,3,17;.. | B/D | 2 |
21,26,27,28;1,2,17;23 | D/M | 1 |
21,26,27,28,1,2,17;.. | D/D ou C/D | 6 |
5,10,11,13,14,21,26,27,28;1,2,17;.. | D/E | 3 |
5,10,11,13,14,26,27;1,17;.. | E/E | 1 |
5,6,10,11,13,14,24,26,27;1,17;.. | E/G | 1 |
5,6,10,11,13,14,26,27;1,17;.. | E/F | 1 |
5,6,11,21,24,26,27,28;1,17;.. | C/G | 1 |
5,6,10,11,14,21,26,27,28;1,17;..;23 | C/F | 1 |
10,11,13,15,16,21,26,27,28;1,17,.. | C/I | 1 |
5,10,11,13,14,15,16,26,27;1,3,17 | A/I | 1 |
5,10,11,13,14,15,16,26,27;1,3,17;.. | B/I | 1 |
Total | 367 |
Populations a | Gm Haplotypes | References | |||||||
---|---|---|---|---|---|---|---|---|---|
Caucasoid | Negroid Khoisan | Mongoloid | |||||||
A,B | C | D | E | F,G | H | I | J,K | ||
Tunisia | 0.602–0.618 | 0.226–0.243 | 0.025–0.051 | 0.083–0.101 | 0.018–0.022 | - | 0.004–0.007 | - | [36] |
Lebanon | 0.692–0.748 | 0.137–0.197 | 0.007–0.033 | 0.007–0.053 | 0.000–0.037 | - | 0.013–0.042 | - | [30,32,35] |
Hungary Czechoslovakia | 0.776–0.777 | 0.138–0.147 | 0.049–0.076 | 0.005–0.013 | 0.005–0.013 | - | 0.005–0.014 | - | [53,54] |
Austria Germany Italy Sardinia | 0.725–0.831 | 0.120–0.190 | 0.049–0.085 | - | - | - | - | - | [44,50,57] |
Ethiopia Sidamos | 0.157 | 0.236 | 0.018 | 0.400 | 0.135 | 0.027 | 0.027 | - | [49] |
Angola | - | - | - | 0.793 | 0.207 | - | - | - | [43] |
Mozambique | - | - | - | 0.716 | 0.260 | 0.024 | - | - | [43] |
San | - | 0.120 | - | 0.295 | 0.030 | 0.555 | - | - | [55] |
Khoikhoi | - | - | 0.048 | 0.429 | 0.190 | 0.333 | - | - | [55] |
Japan | - | 0.437 | 0.151 | - | - | - | 0.261 | 0.151 | [74] |
Km Phenotype Frequency | Populations | ||
---|---|---|---|
Caucasoid | Negroid | Mongoloid | |
Km3 | 80–90 | 40–60 | 40–70 |
Km1,2 | 10–20 | 40–60 | 30–60 |
Km Allele Frequency | Populations | ||
---|---|---|---|
Caucasoid | Negroid | Mongoloid | |
Km3 | 0.90–0.94 | 0.80–0.50 | 0.80–0.50 |
Km1,2 | 0.06–0.08 | 0.20–0.50 | 0.20–0.50 |
Km1 | 0.01 | 0.01 | 0.01 |
Km Alleles | IGKC Alleles | Amino Acid Positions a | ||
---|---|---|---|---|
IMGT | 45.1 | 101 | ||
Exon | (46) | (84) | ||
Eu/Kabat | 153 | 191 | ||
Km3 | IGKC*01, IGKC*02, IGKC*03, IGKC*05 | Ala gcc | Val gtc | |
Km1,2 | IGKC*04 | Ala gcc | Leu ctc | |
Km1 | IGKC*06 b | Val (gtc) | Leu (ctc) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Lefranc, M.-P.; Lefranc, G. Human Gm, Km, and Am Allotypes: WHO/IMGT Nomenclature and IMGT Unique Numbering for Immunoinformatics and Therapeutical Antibodies. BioMedInformatics 2023, 3, 649-690. https://doi.org/10.3390/biomedinformatics3030044
Lefranc M-P, Lefranc G. Human Gm, Km, and Am Allotypes: WHO/IMGT Nomenclature and IMGT Unique Numbering for Immunoinformatics and Therapeutical Antibodies. BioMedInformatics. 2023; 3(3):649-690. https://doi.org/10.3390/biomedinformatics3030044
Chicago/Turabian StyleLefranc, Marie-Paule, and Gérard Lefranc. 2023. "Human Gm, Km, and Am Allotypes: WHO/IMGT Nomenclature and IMGT Unique Numbering for Immunoinformatics and Therapeutical Antibodies" BioMedInformatics 3, no. 3: 649-690. https://doi.org/10.3390/biomedinformatics3030044